-
1مورد إلكتروني
المؤلفون: Derksen, JWG, Vink, GR, Elferink, MA, Roodhart, JML, Verkooijen, HM, van Grevenstein, WMU, Siersema, PD, May, AM, Koopman, M, Beets, GL, Belt, EJT, Berbée, M, Beverdam, FH, Blankenburgh, R, Coene, PPLO, Cruijsen, H, Dekker, JW, van Dodewaard-de Jong, JM, Erdkamp, FLG, Groot, JWH, Haringhuizen, AW, Helgason, HH, Hendriks, MP, de Hingh, IHJT, Hoekstra, R, IJzermans, J.N.M., Jansen, J, Kloppenberg, FWH, van Lent, AU, Los, M, Meijerink, MR, Mekenkamp, L J, Nieboer, P, Peeters, KCMJ, Peters, NA, Polée, MB, Pruijt, JFM, Punt, CJ, van Ufford-Mannesse, PQ, Rietbroek, RC, Schiphorst, AHW, van der Velden, AS, Schrauwen, RWM, Sie, MPS, Simkens, L, Sommeijer, DW, Sonneveld, DJA, Spierings, LEA, Stockmann, HB, Talsma, K, Terheggen, F, ten Tije, AJ, Tjin-a-Ton, MLR, Valkenburg-van Iersel, LBJ, Veenstra, RP, van der Velden, AMT, Vermaas, M, Vles, WJ, Vogelaar, JFJ, van Voorthuizen, T, Vos, AI, Wegdam, JA, Wilt, JHW, Zimmerman, DDE
المصدر: Derksen , JWG , Vink , GR , Elferink , MA , Roodhart , JML , Verkooijen , HM , van Grevenstein , WMU , Siersema , PD , May , AM , Koopman , M , Beets , GL , Belt , EJT , Berbée , M , Beverdam , FH , Blankenburgh , R , Coene , PPLO , Cruijsen , H , Dekker , JW , van Dodewaard-de Jong , JM , Erdkamp , FLG , Groot , JWH , Haringhuizen , AW , Helgason , HH , Hendriks , MP , de Hingh , IHJT , Hoekstra , R , IJzermans , J N M , Jansen , J , Kloppenberg , FWH , van Lent , AU , Los , M , Meijerink , MR , Mekenkamp , L J , Nieboer , P , Peeters , KCMJ , Peters , NA , Polée , MB , Pruijt , JFM , Punt , CJ , van Ufford-Mannesse , PQ , Rietbroek , RC , Schiphorst , AHW , van der Velden , AS , Schrauwen , RWM , Sie , MPS , Simkens , L , Sommeijer , DW , Sonneveld , DJA , Spierings , LEA , Stockmann , HB , Talsma , K , Terheggen , F , ten Tije , AJ , Tjin-a-Ton , MLR , Valkenburg-van Iersel , LBJ , Veenstra , RP , van der Velden , AMT , Vermaas , M , Vles , WJ , Vogelaar , JFJ , van Voorthuizen , T , Vos , AI , Wegdam , JA , Wilt , JHW & Zimmerman , DDE 2021 , ' The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care ' , Scientific Reports , vol. 11 , no. 1 , 3923 .
مصطلحات الفهرس: dk/atira/pure/keywords/researchprograms/AFL001000/EMCOR01; name=EMC OR-01, dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being, article
-
2مورد إلكتروني
المؤلفون: van den Berg, Inge, van de Weerd, S, Roodhart, JML, Vink, GR, Coebergh van den Braak, Robert, Jimenez, CR, Elias, SG, Vliet, D, Koelink, M, Hong, E, van Grevenstein, WMU, van Oijen, MG, Beets-Tan, RGH, van Krieken, J, IJzermans, J.N.M., Medema, JP, Koopman, M
المصدر: van den Berg , I , van de Weerd , S , Roodhart , JML , Vink , GR , Coebergh van den Braak , R , Jimenez , CR , Elias , SG , Vliet , D , Koelink , M , Hong , E , van Grevenstein , WMU , van Oijen , MG , Beets-Tan , RGH , van Krieken , J , IJzermans , J N M , Medema , JP & Koopman , M 2020 , ' Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study ' , BMC Cancer , vol. 20 , no. 1 , 776 .
مصطلحات الفهرس: dk/atira/pure/keywords/researchprograms/AFL001000/EMCMGC025201A; name=EMC MGC-02-52-01-A, dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being, article
-
3مورد إلكتروني
المؤلفون: Buisman, Florian, Homs, Marjolein, Grunhagen, DJ, Filipe, Wills Floris, Bennink, RJ, Besselink, MGH, Rinkes, I, Bruijnen, RCG, Cercek, A, D'Angelica, MI, van Delden, OM, Donswijk, ML, van Doorn, L, Doornebosch, PG, Emmering, Jasper, Erdmann, JI, IJzerman, Nikki, Grootscholten, C, Hagendoorn, J, Kemeny, NE, Kingham, TP, Klompenhouwer, EG, Kok, NFM, Koolen, S, Kuhlmann, KFD, Kuiper, MC, Lam, MGE, Mathijssen, Ron, Moelker, Adriaan, Oomen - de Hoop, Esther, Punt, CJA, Riele, WWT, Roodhart, JML, Swijnenburg, RJ, Prevoo, W, Tanis, PJ, Vermaas, M, Versleijen, MWJ, Veuger, FP, Weterman, MJ, Verhoef, Kees, Groot Koerkamp, B
المصدر: Buisman , F , Homs , M , Grunhagen , DJ , Filipe , W F , Bennink , RJ , Besselink , MGH , Rinkes , I , Bruijnen , RCG , Cercek , A , D'Angelica , MI , van Delden , OM , Donswijk , ML , van Doorn , L , Doornebosch , PG , Emmering , J , Erdmann , JI , IJzerman , N , Grootscholten , C , Hagendoorn , J , Kemeny , NE , Kingham , TP , Klompenhouwer , EG , Kok , NFM , Koolen , S , Kuhlmann , KFD , Kuiper , MC , Lam , MGE , Mathijssen , R , Moelker , A , Oomen - de Hoop , E , Punt , CJA , Riele , WWT , Roodhart , JML , Swijnenburg , RJ , Prevoo , W , Tanis , PJ , Vermaas , M , Versleijen , MWJ , Veuger , FP , Weterman , MJ , Verhoef , K & Groot Koerkamp , B 2019 , ' Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial ' , BMC Cancer , vol. 19 , 327 .
مصطلحات الفهرس: article
-
4دورية أكاديمية
المؤلفون: Franken IA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van der Baan FH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Vink GR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van Grevenstein WMU; Department of Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: j.roodhart@umcutrecht.nl.
المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Sep; Vol. 208, pp. 114207. Date of Electronic Publication: 2024 Jul 10.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Colonic Neoplasms*/mortality , Colonic Neoplasms*/pathology , Colonic Neoplasms*/drug therapy , Patient Reported Outcome Measures* , Neoplasm Staging*, Humans ; Male ; Female ; Chemotherapy, Adjuvant ; Aged ; Middle Aged ; Netherlands ; Oxaliplatin/therapeutic use ; Oxaliplatin/administration & dosage ; Capecitabine/administration & dosage ; Capecitabine/therapeutic use ; Time Factors ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Aged, 80 and over ; Registries
-
5دورية أكاديمية
المؤلفون: Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. Electronic address: m.koopman-6@umcutrecht.nl.
المصدر: The Lancet. Oncology [Lancet Oncol] 2024 Sep; Vol. 25 (9), pp. 1104-1105. Date of Electronic Publication: 2024 Aug 05.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Camptothecin*/administration & dosage , Camptothecin*/analogs & derivatives , Camptothecin*/therapeutic use , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/pathology , Colorectal Neoplasms*/genetics , Immunoconjugates*/administration & dosage , Immunoconjugates*/therapeutic use , Neoplasm Metastasis* , Receptor, ErbB-2*/metabolism , Trastuzumab*/administration & dosage , Trastuzumab*/therapeutic use, Humans ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
-
6دورية أكاديمية
المؤلفون: Kramer A; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, De Boelelaan 1089a, Amsterdam, Noord-Holland 1081 HV, The Netherlands., Greuter MJE; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Schraa SJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Vink GR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Research and Development, IKNL, Utrecht, The Netherlands., Phallen J; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Velculescu VE; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Meijer GA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Broek D; Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Fijneman RJA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Retèl VP; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Coupé VMH; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
المصدر: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Aug 21; Vol. 16, pp. 17588359241266164. Date of Electronic Publication: 2024 Aug 21 (Print Publication: 2024).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
-
7دورية أكاديمية
المؤلفون: van de Weerd S; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Torang A; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van den Berg I; Department of Surgery, Erasmus MC, University Medical center Rotterdam, Rotterdam, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Lammers V; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van den Bergh S; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Brouwer N; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Nagtegaal ID; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Vink GR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., van der Baan FH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Krieken H; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Koster J; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands., Ijzermans JN; Department of Surgery, Erasmus MC, University Medical center Rotterdam, Rotterdam, The Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Medema JP; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
المصدر: International journal of cancer [Int J Cancer] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
-
8دورية أكاديمية
المؤلفون: Filipe WF; Department of Surgery, Erasmus MC Cancer Institute, Erasmus University, Rotterdam, the Netherlands. Electronic address: w.filipe@erasmusmc.nl., Buisman FE; Department of Surgery, Erasmus MC Cancer Institute, Erasmus University, Rotterdam, the Netherlands., Franssen S; Department of Surgery, Erasmus MC Cancer Institute, Erasmus University, Rotterdam, the Netherlands., Krul MF; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Grünhagen DJ; Department of Surgery, Erasmus MC Cancer Institute, Erasmus University, Rotterdam, the Netherlands., Bennink RJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Rotterdam, the Netherlands., Bolhuis K; Department of Medical Oncology, The Netherlands Cancer Center, Amsterdam, the Netherlands., Bruijnen RCG; Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands., Buffart TE; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Burgmans MC; Department of Radiology and Nuclear Medicine, Leiden University Medical Center, Leiden, the Netherlands., van Delden OM; Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Rotterdam, the Netherlands., Doornebosch PG; Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands., Gobardhan PD; Department of Surgery, Amphia Hospital, Breda, the Netherlands., Graven L; Department of Radiology and Nuclear Medicine, Erasmus MC, Erasmus University, Rotterdam, the Netherlands., de Groot JWB; Department of Medical Oncology, Isala, Zwolle, the Netherlands., Grootscholten C; Department of Medical Oncology, The Netherlands Cancer Center, Amsterdam, the Netherlands., Hagendoorn J; Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands., Harmsen P; Department of Surgery, Erasmus MC Cancer Institute, Erasmus University, Rotterdam, the Netherlands., Homs MYV; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University, Rotterdam, the Netherlands., Klompenhouwer EG; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kok NFM; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lam MGEH; Department of Nuclear Medicine, University Medical Center Utrecht, Utrecht, the Netherlands., Loosveld OJL; Department of Medical Oncology, Amphia Hospital, Breda, the Netherlands., Meier MAJ; Department of Radiology and Nuclear Medicine, Isala, Zwolle, the Netherlands., Mieog JSD; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Oostdijk AHJ; Department of Radiology and Nuclear Medicine, Isala, Zwolle, the Netherlands., Outmani L; Department of Surgery, Erasmus MC Cancer Institute, Erasmus University, Rotterdam, the Netherlands., Patijn GA; Department of Surgery, Isala, Zwolle, the Netherlands., Pool S; Department of Radiology and Nuclear Medicine, Amphia Hospital, Breda, the Netherlands., Rietbergen DDD; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Speetjens FM; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Swijnenburg RJ; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands., Versleijen MWJ; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Verhoef C; Department of Surgery, Erasmus MC Cancer Institute, Erasmus University, Rotterdam, the Netherlands., Kuhlmann KFD; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Moelker A; Department of Radiology and Nuclear Medicine, Erasmus MC, Erasmus University, Rotterdam, the Netherlands., Groot Koerkamp B; Department of Surgery, Erasmus MC Cancer Institute, Erasmus University, Rotterdam, the Netherlands. Electronic address: b.grootkoerkamp@erasmusmc.nl.
مؤلفون مشاركون: Dutch HAIP consortium
المصدر: HPB : the official journal of the International Hepato Pancreato Biliary Association [HPB (Oxford)] 2024 Jul; Vol. 26 (7), pp. 919-927. Date of Electronic Publication: 2024 Mar 20.
نوع المنشور: Journal Article; Multicenter Study; Observational Study
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 100900921 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2574 (Electronic) Linking ISSN: 1365182X NLM ISO Abbreviation: HPB (Oxford) Subsets: MEDLINE
مواضيع طبية MeSH: Hepatic Artery*/diagnostic imaging , Infusions, Intra-Arterial*, Aged ; Female ; Humans ; Male ; Middle Aged ; Antineoplastic Agents/administration & dosage ; Incidence ; Infusion Pumps, Implantable ; Liver Circulation ; Liver Neoplasms/surgery ; Methylene Blue/administration & dosage ; Netherlands/epidemiology ; Retrospective Studies ; Single Photon Emission Computed Tomography Computed Tomography ; Technetium Tc 99m Aggregated Albumin/administration & dosage
-
9دورية أكاديمية
المؤلفون: Zwart K; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Nassau SCMW; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van der Baan FH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Snaebjornsson P; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Gestel AJ; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Vink GR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. J.Roodhart@umcutrecht.nl.
المصدر: British journal of cancer [Br J Cancer] 2024 Jul; Vol. 131 (1), pp. 110-116. Date of Electronic Publication: 2024 May 20.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/pathology , Colorectal Neoplasms*/mortality , Proto-Oncogene Proteins B-raf*/genetics , Carbamates*/therapeutic use , Carbamates*/administration & dosage , Cetuximab*/administration & dosage , Cetuximab*/therapeutic use , Sulfonamides*/therapeutic use , Sulfonamides*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Mutation*, Humans ; Female ; Male ; Middle Aged ; Aged ; Aged, 80 and over ; Netherlands/epidemiology ; Adult ; Neoplasm Metastasis ; Treatment Outcome
-
10دورية أكاديمية
المؤلفون: Boon NJ; Oncode Institute, Utrecht, Netherlands.; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands., Oliveira RA; Oncode Institute, Utrecht, Netherlands.; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands., Körner PR; Oncode Institute, Utrecht, Netherlands.; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, Netherlands., Kochavi A; Oncode Institute, Utrecht, Netherlands.; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, Netherlands., Mertens S; Oncode Institute, Utrecht, Netherlands.; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands., Malka Y; Oncode Institute, Utrecht, Netherlands.; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, Netherlands., Voogd R; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., van der Horst SEM; Oncode Institute, Utrecht, Netherlands.; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands., Huismans MA; Oncode Institute, Utrecht, Netherlands.; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands., Smabers LP; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Draper JM; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands., Wessels LFA; Oncode Institute, Utrecht, Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, Netherlands., Haahr P; Oncode Institute, Utrecht, Netherlands.; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands.; Center for Gene Expression, Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Schumacher TNM; Oncode Institute, Utrecht, Netherlands.; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., Snippert HJ; Oncode Institute, Utrecht, Netherlands.; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands., Agami R; Oncode Institute, Utrecht, Netherlands.; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, Netherlands., Brummelkamp TR; Oncode Institute, Utrecht, Netherlands.; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands.
المصدر: Science (New York, N.Y.) [Science] 2024 May 17; Vol. 384 (6697), pp. 785-792. Date of Electronic Publication: 2024 May 16.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE
مواضيع طبية MeSH: Apoptosis* , DNA Damage* , Protein Biosynthesis* , Ribosomes*/metabolism , Tumor Suppressor Protein p53*/metabolism , Tumor Suppressor Protein p53*/genetics, Humans ; Cell Line, Tumor ; Codon/genetics ; Leucine/genetics ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism ; Protein Serine-Threonine Kinases/metabolism ; Protein Serine-Threonine Kinases/genetics ; Signal Transduction ; MAP Kinase Kinase Kinases/genetics ; MAP Kinase Kinase Kinases/metabolism